Compounds > tetramethylpyrazine
Page last updated: 2024-08-21

tetramethylpyrazine and Autosomal Dominant Juvenile Parkinson Disease

tetramethylpyrazine has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, ZH; Li, YN; Peng, Y; Qu, ZY; Xu, ML; Zhang, Q; Zhao, H1
Chen, L; Cheng, L; Liu, H; Liu, X; Ren, Z; Wang, S; Wei, X; Wu, Y; Yuan, Z1

Other Studies

2 other study(ies) available for tetramethylpyrazine and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Tetramethylpyrazine alleviated cytokine synthesis and dopamine deficit and improved motor dysfunction in the mice model of Parkinson's disease.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2014, Volume: 35, Issue:12

    Topics: Analysis of Variance; Animals; Benzofurans; Corpus Striatum; Cytokines; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Excitatory Postsynaptic Potentials; In Vitro Techniques; Male; Mice; Neurons; Parkinsonian Disorders; Patch-Clamp Techniques; Postural Balance; Psychomotor Performance; Pyrazines; Quinolines; Vasodilator Agents

2014
Tetramethylpyrazine Analogue CXC195 Protects Against Dopaminergic Neuronal Apoptosis via Activation of PI3K/Akt/GSK3β Signaling Pathway in 6-OHDA-Induced Parkinson's Disease Mice.
    Neurochemical research, 2017, Volume: 42, Issue:4

    Topics: Animals; Apoptosis; Dopaminergic Neurons; Dose-Response Relationship, Drug; Glycogen Synthase Kinase 3 beta; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Phosphatidylinositol 3-Kinases; Piperazines; Proto-Oncogene Proteins c-akt; Pyrazines; Random Allocation; Signal Transduction

2017